Mylan Technologies Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MYLAN TECHNOLOGIES, and what generic and branded alternatives to MYLAN TECHNOLOGIES drugs are available?
MYLAN TECHNOLOGIES has thirteen approved drugs.
Summary for Mylan Technologies
| US Patents: | 0 |
| Tradenames: | 16 |
| Ingredients: | 9 |
| NDAs: | 13 |
| PTAB Cases with Mylan Technologies as petitioner: | See PTAB cases with Mylan Technologies as petitioner |
Drugs and US Patents for Mylan Technologies
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Technologies | FENTANYL-25 | fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 076258-001 | Jan 28, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Technologies | FENTANYL-50 | fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 076258-002 | Jan 28, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Mylan Technologies | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | buprenorphine hydrochloride; naloxone hydrochloride | FILM;BUCCAL, SUBLINGUAL | 211785-002 | Apr 17, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
